Stay up-to-date with the latest Sciety news

In response to the increasing demand for Sciety’s services, we are happy to announce the addition of three new Communication Specialists to our team. At Sciety, we believe in the importance of clear investor communication. Communication is a fundamental part of what we do, ensuring that we cultivate trust and…

Spring 2023 was an interesting time for Sciety. Our goal is to make scientific breakthroughs in medicine and technology available to people all over the world. This is why we strive to help innovative companies within life science and digital health to grow and reach their full potential. In partnership…

  Tommi Unkuri was appointed a new member of the board of Sciety AB at the general meeting held on June 13th. With extensive experience in building and developing companies within finance and investing in unlisted life science companies, Unkuri is a valuable addition to the board.   Tommi Unkuri…

Sciety, a leading Nordic investment company focusing on innovative life science and health tech companies, along with Sciety Venture Partners, invest EUR 1.5 million in Encare. In the funding round, targeting primarily existing shareholders, Sciety and Sciety Venture Partners made their second investment in Encare, supporting the company’s continued expansion,…

Sciety and Sciety Venture Partners recently completed an investment of EUR 5.3 million in Capitainer, a Swedish medtech company that has developed a unique platform for self-sampling of blood, facilitating remote healthcare solutions and personalized medicine. The capital will be used for sales & marketing and expanding production capacity to…

Sciety and the network Sciety Venture Partners have invested SEK 68 million in the Swedish radioimmunotherapy company Akiram Therapeutics. The investment company Linc AB participated in the share issue with SEK 20 million. Akiram is developing a new type of targeted radiotherapy against incurable cancer that has shown excellent results…

PRESS RELEASE. The Sciety syndicate has invested SEK 26 million in Swedish health tech company Encare, whose SaaS solution enables health care providers to improve surgery outcomes. The new capital will finance Encare’s global expansion and further develop the company’s products. Around 300 million surgeries are performed worldwide annually, and…

PRESS RELEASE. The Swedish pharmaceutical company PharmNovo, which is developing a new type of drug for nerve pain, has raised SEK 67 million in a new share issue led by Sciety. Karolinska Development AB participated in the share issue with SEK 20 million. The new capital will be used to…

PRESS RELEASE. Capitainer, a Swedish MedTech company supplying reliable solutions for self-sampling of blood and plasma, has raised a further SEK 34 million with Sciety and its investment syndicate in a new share issue. The company will use the proceeds to fund additional product validations, sales, and marketing to meet…

NEW COMPANY AT SCIETY. Long waiting time for surgery, deficiencies in patient safety, and high costs for care related to surgery. Healthcare faces significant challenges in Sweden and internationally while the demands for quality-improving measures are increasing. A Swedish health-tech player with an IT solution implementing structure and systematics in…